Clinical outcomes between non-AF and AF
| Total (n=6704) | AF (n=761) | Non-AF (n=5943) | Unadjusted HR (95% CI) | Adjusted HR (95% CI)* | ||||
| N | % | N | % | N | % | |||
| 1-year outcomes | ||||||||
| MACE | 849 | 12.7 | 166 | 21.8 | 683 | 11.5 | 1.97 (1.66 to 2.33) | 1.61 (1.29 to 2.01) |
| Mortality | 373 | 5.6 | 80 | 10.5 | 293 | 4.9 | 2.17 (1.69 to 2.78) | 1.31 (0.95 to 1.80) |
| Myocardial infarction | 123 | 1.8 | 26 | 3.4 | 97 | 1.6 | 2.13 (1.38 to 3.28) | 1.96 (1.11 to 3.46) |
| Cerebrovascular accident | 74 | 1.1 | 18 | 2.4 | 56 | 0.9 | 2.55 (1.50 to 4.33) | 1.45 (0.71 to 2.99) |
| Unplanned revascularisation | 410 | 6.1 | 64 | 8.4 | 346 | 5.8 | 1.48 (1.13 to 1.93) | 1.52 (1.08 to 2.15) |
| Bleeding | 129 | 1.9 | 22 | 2.9 | 107 | 1.8 | 1.65 (1.04 to 2.61) | 1.35 (0.73 to 2.50) |
*Adjusted for age, sex, type 2 diabetes, hypertension, dyslipidaemia, acute coronary syndrome, prior CVA, vascular disease and anticoagulation.
AF, atrial fibrillation; CVA, cerebrovascular accident; MACE, major adverse cardiac event.